{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:50:02Z","timestamp":1792788602586,"version":"4.5.0"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:00:00Z","timestamp":1683763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"name":"GSK"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Increasing prevalence of antimicrobial resistance (AMR), including multidrug resistance (MDR), among\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      (\n                      <jats:italic>E<\/jats:italic>\n                      .\n                      <jats:italic>coli<\/jats:italic>\n                      ) makes treatment of uncomplicated urinary tract infection (uUTI) difficult. We assessed risk factors for fluoroquinolone (FQ)-not-susceptible (NS) and MDR\n                      <jats:italic>E<\/jats:italic>\n                      .\n                      <jats:italic>coli<\/jats:italic>\n                      among US female outpatients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This retrospective cohort study utilized data from female outpatients aged \u2265 12 years with\n                      <jats:italic>E<\/jats:italic>\n                      .\n                      <jats:italic>coli<\/jats:italic>\n                      positive urine culture and oral antimicrobial prescription \u00b1 1 day from index. We assessed patient-level factors within 90 and 91\u2013360 days prior to index as predictors of FQ NS (intermediate\/resistant) and MDR (NS to \u2265 1 drug across \u2265 3 classes)\n                      <jats:italic>E<\/jats:italic>\n                      .\n                      <jats:italic>coli<\/jats:italic>\n                      : age, prior oral antimicrobial dispensing, prior AMR phenotypes, prior urine culture, and prior hospitalization.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 1,858 outpatients with urine-isolated\n                      <jats:italic>E<\/jats:italic>\n                      .\n                      <jats:italic>coli<\/jats:italic>\n                      , 369 (19.9%) had FQ NS and 59 (3.2%) had MDR isolates. After multivariable adjustment, independent risk factors (\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.03) for FQ NS\n                      <jats:italic>E<\/jats:italic>\n                      .\n                      <jats:italic>coli<\/jats:italic>\n                      were older age, prior FQ NS isolates, prior dispensing of FQ, and dispensing of any oral antibiotic. Independent risk factors (\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.02) for MDR were prior extended-spectrum \u03b2-lactamase-producing isolates (ESBL+), prior FQ dispensing, and prior oral antibiotic dispensing.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      In women with uUTI due to\n                      <jats:italic>E<\/jats:italic>\n                      .\n                      <jats:italic>coli<\/jats:italic>\n                      , prior dispensing of FQ or any oral antibiotic within 90 days predicted FQ NS and MDR urine\n                      <jats:italic>E<\/jats:italic>\n                      .\n                      <jats:italic>coli<\/jats:italic>\n                      . Prior urine culture with FQ NS isolates and older age were predictive of FQ NS\n                      <jats:italic>E<\/jats:italic>\n                      .\n                      <jats:italic>coli<\/jats:italic>\n                      . Prior ESBL+ was predictive of MDR\n                      <jats:italic>E<\/jats:italic>\n                      .\n                      <jats:italic>coli<\/jats:italic>\n                      . These data could help identify patients at risk for AMR\n                      <jats:italic>E<\/jats:italic>\n                      .\n                      <jats:italic>coli<\/jats:italic>\n                      and inform empiric prescribing.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0285427","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T13:34:32Z","timestamp":1683812072000},"page":"e0285427","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Older patient age and prior antimicrobial use strongly predict antimicrobial resistance in Escherichia coli isolates recovered from urinary tract infections among female outpatients"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8829-7088","authenticated-orcid":true,"given":"Fanny S.","family":"Mitrani-Gold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith S.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aruni","family":"Mulgirigama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara W.","family":"Trautner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole E.","family":"Scangarella-Oman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalvin C.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish V.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,5,11]]},"reference":[{"key":"pone.0285427.ref001","doi-asserted-by":"crossref","first-page":"1756287219832172","DOI":"10.1177\/1756287219832172","article-title":"An introduction to the epidemiology and burden of urinary tract infections","volume":"11","author":"M Medina","year":"2019","journal-title":"Ther Adv Urol"},{"issue":"1","key":"pone.0285427.ref002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.idc.2013.09.003","article-title":"Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden","volume":"28","author":"B. Foxman","year":"2014","journal-title":"Infect Dis Clin North Am"},{"issue":"1","key":"pone.0285427.ref003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ucl.2007.09.004","article-title":"Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis","volume":"35","author":"LE Nicolle","year":"2008","journal-title":"Urol Clin North Am"},{"issue":"5","key":"pone.0285427.ref004","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"K Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"pone.0285427.ref005","unstructured":"Bonkat G, Bartoletti R, Bruy\u00e8re F, Cai T, Geerlings SE, K\u00f6ves B, et al. Urological infections. Arnhem, the Netherlands: EAU Guidelines Office; 2020."},{"issue":"11","key":"pone.0285427.ref006","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1093\/cid\/ciab560","article-title":"Antimicrobial resistance trends in urine Escherichia coli isolates from adult and adolescent females in the United States from 2011\u20132019: rising ESBL strains and impact on patient management","volume":"73","author":"KS Kaye","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"3","key":"pone.0285427.ref007","doi-asserted-by":"crossref","first-page":"e0115822","DOI":"10.1128\/spectrum.01158-22","article-title":"A multicenter comparison of carbapenem-nonsusceptible Enterobacterales and Pseudomonas aeruginosa rates in the US (2016 to 2020): facility-reported rates versus rates based on updated Clinical Laboratory and Standards Institute breakpoints","volume":"10","author":"V Gupta","year":"2022","journal-title":"Microbiol Spectr"},{"key":"pone.0285427.ref008","unstructured":"Clinical and Laboratory Standards Institute. 21st ed. Performance standards for antimicrobial susceptibility testing. CLSI supplement M100. Wayne, PA, USA: The Clinical and Laboratory Standards Institute; 2011."},{"issue":"4","key":"pone.0285427.ref009","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1128\/AAC.06060-11","article-title":"In vitro antimicrobial resistance of urinary Escherichia coli isolates among U.S. Outpatients from 2000 to 2010","volume":"56","author":"GV Sanchez","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0285427.ref010","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jgar.2020.10.020","article-title":"Resistance among urinary tract pathogens collected in Europe during 2018","volume":"23","author":"IA Critchley","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"issue":"6","key":"pone.0285427.ref011","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/2042098614554919","article-title":"Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem","volume":"5","author":"C Llor","year":"2014","journal-title":"Ther Adv Drug Saf"},{"issue":"10","key":"pone.0285427.ref012","doi-asserted-by":"crossref","first-page":"e00862","DOI":"10.1128\/AAC.00862-20","article-title":"Escherichia coli resistance to fluoroquinolones in community-acquired uncomplicated urinary tract infection in women: a systematic review","volume":"64","author":"AE Stapleton","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0285427.ref013","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1476-0711-8-27","article-title":"Empiric antibiotic therapy in acute uncomplicated urinary tract infections and fluoroquinolone resistance: a prospective observational study","volume":"8","author":"C Aypak","year":"2009","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"8","key":"pone.0285427.ref014","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s10096-016-2673-1","article-title":"Etiology and antibiotic susceptibility of bacterial pathogens responsible for community-acquired urinary tract infections in poland","volume":"35","author":"E Stefaniuk","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"pone.0285427.ref015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10096-016-2776-8","article-title":"Uropathogen distribution and antimicrobial susceptibility in uncomplicated cystitis in Belgium, a high antibiotics prescribing country: 20-year surveillance","volume":"36","author":"S Heytens","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"pone.0285427.ref016","doi-asserted-by":"crossref","first-page":"4192908","DOI":"10.1155\/2017\/4192908","article-title":"Antimicrobial resistance patterns in women with positive urine culture: Does menopausal status make a significant difference?","volume":"2017","author":"P Miotla","year":"2017","journal-title":"Biomed Res Int"},{"issue":"4","key":"pone.0285427.ref017","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10156-012-0419-2","article-title":"Sensitivities of major causative organisms isolated from patients with acute uncomplicated cystitis against various antibacterial agents: results of subanalysis based on the presence of menopause","volume":"18","author":"T Matsumoto","year":"2012","journal-title":"J Infect Chemother"},{"issue":"5","key":"pone.0285427.ref018","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ijantimicag.2009.04.012","article-title":"The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections","volume":"34","author":"GC Schito","year":"2009","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"pone.0285427.ref019","doi-asserted-by":"crossref","first-page":"e4552","DOI":"10.1093\/cid\/ciaa1031","article-title":"Antibiotic multidrug resistance of Escherichia coli causing device- and procedure-related infections in the United States reported to the national healthcare safety network, 2013\u20132017","volume":"73","author":"AP Kourtis","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"6583","key":"pone.0285427.ref020","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1126\/science.abg9868","article-title":"Minimizing treatment-induced emergence of antibiotic resistance in bacterial infections","volume":"375","author":"M Stracy","year":"2022","journal-title":"Science"},{"issue":"9","key":"pone.0285427.ref021","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.cmi.2017.12.026","article-title":"Effect of outpatient antibiotics for urinary tract infections on antimicrobial resistance among commensal Enterobacteriaceae: a multinational prospective cohort study","volume":"24","author":"AJ Stewardson","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"pone.0285427.ref022","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/cid\/cir301","article-title":"Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection","volume":"53","author":"V Stevens","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"12","key":"pone.0285427.ref023","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1017\/ice.2015.220","article-title":"A comprehensive assessment across the healthcare continuum: risk of hospital-associated clostridium difficile infection due to outpatient and inpatient antibiotic exposure","volume":"36","author":"SY Tartof","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"pone.0285427.ref024","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7326\/M18-3640","article-title":"Excess antibiotic treatment duration and adverse events in patients hospitalized with pneumonia: a multihospital cohort study","volume":"171","author":"VM Vaughn","year":"2019","journal-title":"Ann Intern Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0285427","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T13:34:59Z","timestamp":1683812099000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0285427"}},"subtitle":[],"editor":[{"given":"Kwame Kumi","family":"Asare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,5,11]]},"references-count":24,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0285427","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,11]]}}}